Literature DB >> 35323975

Natural Killer Cell-Mediated Antibody-Dependent Cellular Cytotoxicity Against SARS-CoV-2 After Natural Infection Is More Potent Than After Vaccination.

Gereon J Rieke1, Kathrin van Bremen1, Jenny Bischoff1, Michael ToVinh1, Malte B Monin1, Stefan Schlabe1,2, Jan Raabe1, Kim M Kaiser1, Claudia Finnemann1, Alexandru Odainic3,4, Anushka Kudaliyanage3, Eicke Latz3, Christian P Strassburg1, Christoph Boesecke1,2, Susanne V Schmidt3, Benjamin Krämer1, Jürgen K Rockstroh1,2, Jacob Nattermann1,2.   

Abstract

We compared the ability of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike-specific antibodies to induce natural killer cell-mediated antibody-dependent cellular cytotoxicity (ADCC) in patients with natural infection and vaccinated persons. Analyzing plasma samples from 39 coronavirus disease 2019 (COVID-19) patients and 11 vaccinated individuals, significant induction of ADCC could be observed over a period of more than 3 months in both vaccinated and recovered individuals. Although plasma antibody concentrations were lower in recovered patients, we found antibodies elicited by natural infection induced a significantly stronger ADCC response compared to those induced by vaccination, which may affect protection conferred by vaccination.
© The Author(s) 2022. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  ADCC; COVID-19; NK cell; mRNA vaccine

Mesh:

Substances:

Year:  2022        PMID: 35323975      PMCID: PMC8992321          DOI: 10.1093/infdis/jiac060

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  2 in total

1.  Taking on SARS-CoV-2.

Authors:  Paola Kučan Brlić; Ilija Brizić
Journal:  Elife       Date:  2022-06-28       Impact factor: 8.713

2.  Antibodies: A Double Leg Takedown Against COVID-19.

Authors:  Mario U Mondelli
Journal:  J Infect Dis       Date:  2022-05-16       Impact factor: 7.759

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.